BIOMAT Database Logo BIOMAT Database Logo

5'-Hydrogenphosphonates of anti-HIV nucleoside analogues revisited: controversial mode of action. 1993

G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Laboratoire de Chimie Bioorganique, U.R.A. C.N.R.S. n. 488, Université de Montpellier II, Sciences et Techniques du Languedoc, Montpellier, France.

The monomeric and symmetrical dimeric 5'-hydrogenphosphonate derivatives of AZT were prepared and evaluated for their inhibitory properties against HIV-1 in several cell lines. The synthesis of the compounds was achieved by reaction of AZT with in situ prepared phosphorus tris(imidazolide) or with phosphonic acid in the presence of pivaloyl chloride. The two title compounds showed in vitro anti-HIV activity similar to (but not better than) that of AZT in three cell lines which were not deficient in thymidine kinase. On the other hand they were inactive in CEM-TK- cells. Pharmacokinetic studies in several media corroborate the assumption that these compounds must not be considered as 'true antiviral agents', but that they act by releasing their nucleoside entity.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013942 Thymine Nucleotides Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054306 Dideoxynucleotides The phosphate esters of DIDEOXYNUCLEOSIDES. Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide

Related Publications

G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
[Nucleoside analogues as anti-herpes agents and their mode of action].
July 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Evaluation of anti-HIV-1 mutagenic nucleoside analogues.
January 2015, The Journal of biological chemistry,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
May 2015, ChemMedChem,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Phosphodiester amidates of allenic nucleoside analogues: anti-HIV activity and possible mechanism of action.
August 1996, Journal of medicinal chemistry,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Anti-HSV nucleoside and non-nucleoside analogues: spectroscopic characterisation of naphthyl and coumarinyl amides and their mode and mechanism of antiviral action.
July 2023, 3 Biotech,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues.
May 2008, Bioorganic & medicinal chemistry,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.
August 1992, Hospital practice (Office ed.),
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
[Nucleoside analogues of 5-hydroxymethyluracil].
January 1972, Justus Liebigs Annalen der Chemie,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Trends in the design of nucleoside analogues as anti-HIV drugs.
January 2002, Current pharmaceutical design,
G Gosselin, and C Périgaud, and I Lefebvre, and A Pompon, and A M Aubertin, and A Kirn, and T Szabo, and J Stawinski, and J L Imbach
Phosphodiester amidates of unsaturated nucleoside analogues: synthesis and anti-HIV activity.
July 1997, Journal of medicinal chemistry,
Copied contents to your clipboard!